Sionna Therapeutics (SION) Shares Outstanding (Weighted Average) (2024 - 2026)

Sionna Therapeutics has disclosed Shares Outstanding (Weighted Average) across 3 years of filings, most recently posting $44.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $44.9 million, up 68.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.9 million (up 68.9% YoY), and the FY2025 annual result was $40.0 million, up 935.6% from the prior year.
• Shares Outstanding (Weighted Average) came in at $44.9 million for Q1 2026 at Sionna Therapeutics, up from $40.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $44.9 million in Q1 2026 to a low of $3.1 million in Q1 2024.
• The 3-year median for Shares Outstanding (Weighted Average) is $26.6 million (2025), against an average of $22.1 million.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 1034.33% in 2025 and jumped 68.9% in 2026, its largest moves.
• Sionna Therapeutics' Shares Outstanding (Weighted Average) stood at $3.9 million in 2024, then soared by 935.6% to $40.0 million in 2025, then gained by 12.41% to $44.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $44.9 million (Q1 2026), $40.0 million (Q4 2025), and $38.4 million (Q3 2025), per Business Quant data.